| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1309568B1 [(quinazolin-4-yl)piperazin-4-yl]thiocarboxamide compounds as inhibitors of the phosphorylation of a PDGF receptor |
| 02/16/2011 | CN101978060A Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/16/2011 | CN101978059A Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 02/16/2011 | CN101978054A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 02/16/2011 | CN101977945A Anti-microbial polymers and their compositions |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977908A (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 02/16/2011 | CN101977906A 4-pyridinone compounds and their use for cancer |
| 02/16/2011 | CN101977905A 4-pyridinone compounds and their use for cancer |
| 02/16/2011 | CN101977631A Polymer conjugate of physiologically active substance |
| 02/16/2011 | CN101977620A Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 02/16/2011 | CN101977619A Soluble complexes of curcumin |
| 02/16/2011 | CN101977608A Pharmaceutical composition comprising chlorine e6-folic acid conjugated compound and chitosan for treatment of cancer |
| 02/16/2011 | CN101977607A Pterin based therapies for inflammatory conditions |
| 02/16/2011 | CN101977599A Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 02/16/2011 | CN101974557A Bifidobacterium pBES-tk recombinant vector for targeted therapy of solid tumor and application thereof |
| 02/16/2011 | CN101974535A Preparation and application of novel anti-ErbB2 humanized antibody MIL12 |
| 02/16/2011 | CN101974534A NRG1 gene coding sequence and application thereof |
| 02/16/2011 | CN101974533A siRNA molecule inhibiting Bc1-2 gene expression and application thereof |
| 02/16/2011 | CN101974532A SiRNA molecule for interfering expression of Bcl-2 gene and application thereof |
| 02/16/2011 | CN101974529A TGF-beta specific siRNA containing free triphosphoric acid group and application thereof |
| 02/16/2011 | CN101974480A Liver engrafting cells, assays, and uses thereof |
| 02/16/2011 | CN101974248A Method for separating tea pigment components |
| 02/16/2011 | CN101974094A Method for comprehensively extracting cudrania tricuspidata polysaccharides and flavones |
| 02/16/2011 | CN101974086A Preparation method and applications of anti-latent membrane protein LMP2A monoclonal antibody |
| 02/16/2011 | CN101974076A Cyclic peptide for inhibiting cell proliferation and blood vessel hyperplasia induced by basic fibroblast growth factors |
| 02/16/2011 | CN101974069A High-efficiency binding peptide in DNA binding region protein of FoxM1c and method for acquiring polypeptide structure sequence |
| 02/16/2011 | CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 02/16/2011 | CN101974067A Solasodine-3-O-alpha-L-rhamnoside as well as preparation method and application thereof |
| 02/16/2011 | CN101974060A Semisynthesis compound with antitumor activity and application thereof |
| 02/16/2011 | CN101974016A Amide compound and preparation method and applications thereof |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101973989A Thiazole amide compound and medicinal application thereof for treating malignancy |
| 02/16/2011 | CN101973987A Epothilone analogue, preparation method as well as medicine composition and application thereof |
| 02/16/2011 | CN101973935A Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 02/16/2011 | CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 02/16/2011 | CN101972493A Visualized iodized oil-5-fluorouracil loaded polylactic acid microsphere preparation and preparation method thereof |
| 02/16/2011 | CN101972480A Docetaxel polymeric micelle medicine composition taking amino acid as stabilizing agent |
| 02/16/2011 | CN101972478A 抗体治疗 Antibody therapy |
| 02/16/2011 | CN101972454A Medicament for treating lymphoma |
| 02/16/2011 | CN101972448A Chinese medicinal composition for treating liver cancer |
| 02/16/2011 | CN101972431A Medicinal composition for inhibiting angiogenesis in breast cancer cells and preparation method thereof |
| 02/16/2011 | CN101972425A Multifunctional jerusalem artichoke capsules for treating diabetes by nourishing pancreas, eliminating root causes and suppressing cancer |
| 02/16/2011 | CN101972387A Medicine for external application for treating early-stage and mid--stage breast cancers |
| 02/16/2011 | CN101972385A Method for preparing general flavone in star-of-Bethlehem and application thereof to antitumor, anti-inflammatory and analgesic medicines |
| 02/16/2011 | CN101972358A Compound lucid ganoderma health-care tea |
| 02/16/2011 | CN101972350A External plaster for treating hepatocarcinoma |
| 02/16/2011 | CN101972347A Method for preparing Chinese medicinal composition soft capsules for treating hyperplasia of mammary glands and breast cancer |
| 02/16/2011 | CN101972290A Extraction process of scabrous doellingeria herb total saponin |
| 02/16/2011 | CN101972286A New application of valeriana jatamansi jones total flavonoids |
| 02/16/2011 | CN101972283A Preparation method of common wedgelet fern herb total flavone |
| 02/16/2011 | CN101972267A Application of dihydro aromatic naphthalene compound in preparation of medicaments for treating and preventing cancers |
| 02/16/2011 | CN101972250A Application of compound N1-(5-(butyl)-1, 3, 4-thiadiazole-2-yl)-N3-(3-chlorphenyl) urea |
| 02/16/2011 | CN101972247A Medicinal application of 15-benzyl subunit-1 4-deoxy-11,12-dehydrogenation andrographolide derivative |
| 02/16/2011 | CN101972246A Medicament for treating cancer, preparation method thereof and application thereof to preparation of medicaments |
| 02/16/2011 | CN101972235A Surfactant-containing Lonidamine amorphous multielement solid dispersion and preparation method thereof |
| 02/16/2011 | CN101972232A Eudragit S100 coated curcumin pectin microsphere and preparation method thereof |
| 02/16/2011 | CN101972227A Method for preparing erianin self-emulsifying preparation |
| 02/16/2011 | CN101653466B Composition for treating cancers |
| 02/16/2011 | CN101569607B Di-demethoxycurcumin precursor liposome and preparation method thereof |
| 02/16/2011 | CN101538245B One-class pyridazinone compounds and preparation method and application thereof |
| 02/16/2011 | CN101518593B Traditional Chinese medicine composition for curing hyperplasia of mammary glands and resisting tumors and preparation method thereof |
| 02/16/2011 | CN101508739B Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 02/16/2011 | CN101475621B Method for purifying clofarabine by using chromatographic column |
| 02/16/2011 | CN101422723B Extraction method of flavonoid anti-tumor active ingredient in barbat skullcap |
| 02/16/2011 | CN101396432B Method for concentrating and separating flavonoids from toona sinensis leaves |
| 02/16/2011 | CN101381392B Pentacyclic triterpene saponins compounds, preparation method and use |
| 02/16/2011 | CN101254209B Calf spleen extract injection prepared by inphase opposition column chromatography and preparation thereof |
| 02/16/2011 | CN101249262B Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 02/16/2011 | CN101238106B Fluoro substituted 2-oxo azepan derivatives |
| 02/16/2011 | CN101220037B 10-substitution homocamptothecin compounds and uses |
| 02/16/2011 | CN101218241B Pyrrolopyridine derivatives as protein kinase inhibitors |
| 02/16/2011 | CN101111509B Novel pyrimidine nucleoside compound or its salt |
| 02/15/2011 | USRE42150 Binding proteins for recognition of DNA |
| 02/15/2011 | US7888473 Non-functional P2X7 receptor |
| 02/15/2011 | US7888468 Recombinant copper containing protein for use in prevention and treatment of cell proliferative dsorders and infection |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 02/15/2011 | US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/15/2011 | US7888341 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide; antitumor; antiproliferative agent; synergistic therapy for resistant; Bcr/Abl, leukemia |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887794 Lactic acid bacteria and their use in the treatment of cancer |
| 02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2501651C Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 02/15/2011 | CA2483594C Use of edg receptor binding agents in cancer |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2461572C Polycyclic compounds having anti-tumor activity |